FDA DeviceClass IINotable

FDA Recall: Atellica CH Enzymatic Hemoglobin A1c (A1c_E). Material Number: 11097536.

Date: 2026-07-15
Brand: Siemens Healthcare Diagnostics, Inc.
Category: Medical Device
FDA Class: Class II

Description

The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.

Hazard

The potential for intermittent well-to-well bias on the A1c_E assay on the Atellica CH and Atellica CI analyzer which could cause falsely depressed or falsely elevated HbA1c patient results.

Remedy

24,077 units

Related Recalls